CLINICAL_TRIALS
trial_result
· 2013-07-02
Clinical Trial Update: Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease [Phase 2]
Summary
Phase 2 safety and efficacy study of AC-3933 in adults with mild to moderate Alzheimer's disease has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-07-02